Company research
Medicale Corp.
CIK 1827855Updated Sep 24, 2026
SecurityMCLE · OTC · equity
MCLE price & chart
Loading TradingView…
OTC:MCLE on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 0Source | 159Source | 159Source | 0Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | — | 0Source |
| Current assets: | ||||
| Assets, CurrentUSD | 0Source | 159Source | 159Source | 0Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 140,086Source | 99,092Source | — | — |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 592Source | 592Source | 592Source | 592Source |
| Additional Paid in CapitalUSD | 76,320Source | 76,320Source | 76,320Source | 25,128Source |
| Retained Earnings (Accumulated Deficit)USD | -216,998Source | -175,845Source | -117,632Source | -80,494Source |
| Stockholders' Equity Attributable to ParentUSD | -140,086Source | -98,933Source | -40,720Source | -54,774Source |
| Liabilities and EquityUSD | 0Source | 159Source | 159Source | 0Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 33,652Source | 15,507Source | 40,879Source | 54,774Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -41,153Source | — | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 10,644Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -23,008Source | -83,585Source | -25,739Source | -24,619Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | 0Source | 0Source | 0Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 22,849Source | 83,585Source | 25,898Source | 6,144Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 0Source | 159Source | 159Source | 0Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 0Source | 0Source | 0Source | 0Source |
| Income Taxes Paid, NetUSD | 0Source | 0Source | 0Source | 0Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | — | — | — | 2,400Source |
| General and Administrative ExpenseUSD | 33,493Source | 54,707Source | 37,593Source | 46,419Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | 7,200Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | -58,213Source | -37,593Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | 0Source | 455Source | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| InterestExpenseNonoperatingUSD | — | 3,506Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -41,153Source | -58,213Source | -37,138Source | -46,419Source |
| Operating ExpensesUSD | 33,493Source | 54,707Source | 37,593Source | 46,419Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | — | — | — | 0Source |
| Operating Income (Loss)USD | -33,493Source | -54,707Source | -37,593Source | -46,419Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | -58,213Source | -37,593Source | -46,419Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -41,153Source | -58,213Source | -37,138Source | -46,419Source |
| Earnings Per Share, BasicUSD per share | -0.01Source | -0.01Source | -0.01Source | -0.01Source |
| Earnings Per Share, DilutedUSD per share | -0.01Source | -0.01Source | -0.01Source | -0.01Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 5,920,000Source | 5,920,000Source | 5,920,000Source | 5,920,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 5,920,000Source | 5,920,000Source | 5,920,000Source | 5,920,000Source |
| Interest Expense (non-operating)USD | — | 3,506Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | — | — | — | 2,400Source |
| General and Administrative ExpenseUSD | 33,493Source | 54,707Source | 37,593Source | 46,419Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | -58,213Source | -37,593Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | 0Source | 455Source | — |
| Interest Expense, DebtUSD | 7,501Source | — | — | — |
| Operating ExpensesUSD | 33,493Source | 54,707Source | 37,593Source | 46,419Source |
| Other ExpensesUSD | 7,660Source | 3,506Source | — | — |